Notice of clarification to drug manufacturers and sponsors: Canadian-specific considerations in risk management plans

Name: Notice of clarification to drug manufacturers and sponsors: Canadian-specific considerations in risk management plans
Creator: Health Canada
License: https://open.canada.ca/en/open-government-licence-canada

Notice of clarification to drug manufacturers and sponsors: Canadian-specific considerations in risk management plans is an open dataset from Health Canada with 2 files (HTML); catalogue record updated 2024-04-04. On CanQuery you can follow the original downloads. Files are available in English and French.

We are issuing this notice to help drug manufacturers and sponsors when preparing the Canadian-specific considerations and elements in the risk management plans (RMPs) for certain drug products. This notice describes what is required for certain drug products.

Publisher: Health Canada
Resources: 2
Catalogue metadata updated: 2024-04-04

Data overview

Formats: HTML
File languages: English, French

Official sources and licences

Government of Canada Open Data
Open Government Licence – Canada

Resources

Notice of clarification to drug manufacturers and sponsors: Canadian-specific considerations in risk management plans (English, HTML) HTML · Download HTML
Notice of clarification to drug manufacturers and sponsors: Canadian-specific considerations in risk management plans (French, HTML) HTML · Download HTML

Related open data

Health Canada